Both companies are active in the global aesthetic market, with IRIDEX’ specialty in vascular treatments. The combination is expected to improve Cutera’s presence among primary care physicians. The transaction has been approved by both board of directors and is expected to close early this year.
Related Articles on Supply Chain:
Idaho’s Parkway Surgery Center Makes Significant Investment in New Equipment
FDA Bans Oridion Systems From Importing Medical Devices Into the U.S.
Massachusetts Life Sciences Center Awards $2.2M in Loans to Medical Technology Startups
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.